Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pramodini MedicareNSE:PRAMODINI -2.01%19 Return-on-Tangible-Equity is 39.13% as of Mar. 2026, which is 12% above its 10-year median of 35.07. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 586 Healthcare Providers & Services companies, Pramodini Medicare ranks better than 50% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Pramodini Medicare's annualized net income for the quarter that ended in Mar. 2026 was ₹192.3 Mil. Pramodini Medicare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹491.5 Mil. Therefore, Pramodini Medicare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 39.13%.
The historical rank and industry rank for Pramodini Medicare's Return-on-Tangible-Equity or its related term are showing as below:
NSE:PRAMODINI'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 10.76 Med: 35.07 Max: 39.09
Current: 10.76
During the past 4 years, Pramodini Medicare's highest Return-on-Tangible-Equity was 39.09%. The lowest was 10.76%. And the median was 35.07%.
NSE:PRAMODINI's Return-on-Tangible-Equity is ranked better than 50% of 586
companies
in the Healthcare Providers & Services industry
Industry Median: 10.74
vs NSE:PRAMODINI: 10.76
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Pramodini Medicare Return-on-Tangible-Equity Related Terms
Pramodini Medicare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Pramodini Medicare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:PRAMODINI vs HCA, THC, EHC: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Pramodini Medicare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pramodini Medicare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Pramodini Medicare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 39.13% mean?
Pramodini Medicare (NSE:PRAMODINI) has a Return-on-Tangible-Equity of 39.13% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Pramodini Medicare and its competitors. This is 12% above median its historical median of 35.07. Over the past decade, Pramodini Medicare's Return-on-Tangible-Equity has ranged from 10.76 to 39.09. According to the industry distribution chart, Pramodini Medicare ranks #293 out of 586 companies in the Healthcare Providers & Services industry, placing it in the top 50%.
Is Pramodini Medicare's Return-on-Tangible-Equity too high?
Pramodini Medicare's current Return-on-Tangible-Equity of 39.13% is 12% above median its 10-year median of 35.07. Over the past 10 years, this metric has ranged from a low of 10.76 to a high of 39.09. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.74. Pramodini Medicare's value of 39.13% is 264.3% above this industry median. Based on the distribution chart, Pramodini Medicare ranks #293 out of 586 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pramodini Medicare ranks #293 out of 586 companies for Return-on-Tangible-Equity. This puts Pramodini Medicare in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.74. Pramodini Medicare's value of 39.13% is 264.3% above this benchmark. Historically, Pramodini Medicare's own Return-on-Tangible-Equity has ranged from 10.76 to 39.09 over the past decade. While the company's 10-year median is 35.07 vs. the industry median of 10.74, Pramodini Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.74, based on 586 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pramodini Medicare's current Return-on-Tangible-Equity of 39.13% is 264.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Pramodini Medicare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pramodini Medicare's current Return-on-Tangible-Equity is 39.13%, which is 12% above median its own 10-year median of 35.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current Return-on-Tangible-Equity of 39.13%. The current Return-on-Tangible-Equity is 39.13%, which is 12% above median its 10-year median of 35.07 and 264.3% above the Healthcare Providers & Services industry median of 10.74. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current Return-on-Tangible-Equity is 39.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score
Get the complete analysis for NSE:PRAMODINI
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PRAMODINI has been successfully added to your 
